针对JAK3共价抑制剂的有效虚拟选策略:结合多合规共识计算与共价对接
Jingyu Zhu1, Genhong Qiu2, Lei Xu3
1School of Life Sciences and Health Engineering, Jiangnan University, Wuxi, 214122, Jiangsu, China. jingyuzhu@jiangnan.edu.cn.
Molecular diversity
|August 21, 2025
概括
研究人员开发了一种新的虚拟查方法,用于发现选择性Janus激酶3 (JAK3) 协同抑制剂的炎症性疾病. 这种方法通过提高JAK3抑制剂的选择性来增强药物发现.
科学领域:
- 生物化学
- 医学化学
- 计算生物学
背景情况:
- 过度激活雅努斯酶3 (JAK3) 与炎症和自身免疫性疾病有关.
- 由于高激酶同质性,现有的JAK3抑制剂缺乏选择性.
- 共价抑制剂为改善JAK3选择性提供了一个有希望的策略.
研究的目的:
- 开发和验证一个层次化的虚拟查级联,用于识别新的共价JAK3抑制剂.
- 通过共价对接方法增强JAK3抑制剂的选择性.
- 在化学数据库中选潜在的共价JAK3抑制剂.
主要方法:
- 一个层次的虚拟选级联,结合非共价和共价对接.
- 通过药模拟和非共价分子对接进行虚拟选.
- 在JAK3中准CYS909的共价分子对接.
- 对选方法的准确性和效率进行验证.
主要成果:
- 开发的虚拟查级联显示出高准确性和效率.
- 对SPECS数据库的查发现了几种潜在的共价JAK3抑制剂.
- 已识别的化合物在炎症条件下有望向JAK3.
结论:
- 层次化的虚拟查级联是发现选择性共价JAK3抑制剂的有效策略.
- 这种方法有助于开发针对性治疗炎症和自身免疫性疾病.
- 鉴定出新的共价JAK3抑制剂,需要进一步调查.
更多相关视频
08:49Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
523
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
654
相关概念视频
Protein-Drug Binding: Determination Methods
302
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
302
Conserved Binding Sites
1.7K
1.7K
Protein-Drug Binding: Mechanism and Kinetics
931
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
931
